ArticleScientific reports2021
The role of good governance in the race for global vaccination during the COVID-19 pandemic.
Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 42 citations in OpenAlex.
- Acceptance of the COVID-19 Booster Vaccine Amid the Omicron JN.1 Surge in Southern Bangladesh: A Comparative Analysis of Rural-Urban Disparities.Risk analysis : an official publication of the Society for Risk Analysis · 2026Observational
- Editorial: Health services and economic inequalities through the lens of sustainable development.Frontiers in public health · 2026Article
- Corruption risks in COVID-19 vaccine deployment: lessons learned for future pandemic preparedness.Globalization and health · 2025Article
- Factors shaping Covid-19 vaccine acceptability among young people in South Africa and Nigeria: An exploratory qualitative study.PLOS global public health · 2025Article
- The COVID-19 pandemic and economic recovery: The mediating role of governance, a global perspective.Heliyon · 2024Article
- Can redistribution of vaccine improve global welfare? Lessons from COVID-19.The European journal of health economics : HEPAC : health economics in prevention and care · 2024Article
- Governance and Public Health Decision-Making During the COVID-19 Pandemic: A Scoping Review.Public health reviews · 2024Article
- Shared health governance, mutual collective accountability, and transparency in COVAX: A qualitative study triangulating data from document sampling and key informant interviews.Journal of global health · 2023Article
- Acceptance of COVID-19 vaccine booster dose among the people of Bangladesh: A cross-sectional study.Heliyon · 2023Article
- National governance and excess mortality due to COVID-19 in 213 countries: a retrospective analysis and perspectives on future pandemics.Globalization and health · 2023Review
- Research agenda for using artificial intelligence in health governance: interpretive scoping review and framework.BioData mining · 2023Article
- Unveiling Vaccine Hesitancy on Twitter: Analyzing Trends and Reasons during the Emergence of COVID-19 Delta and Omicron Variants.Vaccines · 2023Article
- How can COVID-19 vaccines benefit people? A study based on the theory of the commons.Human vaccines & immunotherapeutics · 2023Article
- COVID-19 Vaccination Program Data Analysis Based on Regional Status and Day Type: A Study from West Java Province, Indonesia.Healthcare (Basel, Switzerland) · 2023Article
- The evaluation ofJournal of drug delivery science and technology · 2023Article
- Article
- Determinants of COVID-19 vaccination worldwide: WORLDCOV, a retrospective observational study.Frontiers in public health · 2023Observational
- Institutional quality and COVID-19 vaccination: does decentralization matter?Letters in spatial and resource sciences · 2023Article
- COVID-19 vaccine equity in doldrums: Good governance deficits.Public administration and development : a journal of the Royal Institute of Public Administration · 2022Article
- Attitude towards COVID-19 vaccination among healthcare workers: a cross sectional study from Egypt.BMC health services research · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Governments have developed and implemented various policies and interventions to fight the COVID-19 pandemic. COVID-19 vaccines are now being produced and distributed globally. This study investigated the role of good governance and government effectiveness indicators in the acquisition and administration of COVID-19 vaccines at the population level. Data on six World Bank good governance indicators for 172 countries for 2019 and machine-learning methods (K-Means Method and Principal Component Analysis) were used to cluster countries based on these indicators and COVID-19 vaccination rates. XGBoost was used to classify countries based on their vaccination status and identify the relative contribution of each governance indicator to the vaccination rollout in each country. Countries with the highest COVID-19 vaccination rates (e.g., Israel, United Arab Emirates, United States) also have higher effective governance indicators. Regulatory Quality is the most important indicator in predicting COVID-19 vaccination status in a country, followed by Voice and Accountability, and Government Effectiveness. Our findings suggest that coordinated global efforts led by the World Health Organization and wealthier nations may be necessary to assist in the supply and distribution of vaccines to those countries that have less effective governance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.